☆ 4.7 Article

Refining Immunogenicity through Intradermal Delivery of Outer Membrane Vesicles against Shigella flexneri in Mice

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice

Ushasi Bhaumik et al.

Summary: In today's world and mostly in low and middle income countries, Shigella flexneri and Shigella sonnei remains the major causative agent of clinical bacillary dysentery. A tetravalent Outer Membrane Vesicle (OMVs) based immunogen was formulated using the most commonly circulating Shigella strains. The results showed that the tetravalent OMVs immunogen induced significant and persistent immune response and provided protection against six heterologous Shigella strains.

MICROBES AND INFECTION (2023)

添加到收藏夹

Review Immunology

Improved DNA Vaccine Delivery with Needle-Free Injection Systems

Carmen Ledesma-Feliciano et al.

Summary: DNA vaccines have advantages such as safety, rapid design, easy manufacture, and thermostability. However, the poor immunogenicity associated with the cellular uptake of DNA delivered by needle and syringe is a major drawback. Various techniques, including needle-free injection systems, have been used to enhance the immunogenicity and efficacy of DNA vaccines. NFIS has shown non-inferior immunogenicity and enhanced responses compared to other delivery methods.

VACCINES (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Toward a Shigella Vaccine: Opportunities and Challenges to Fight an Antimicrobial-Resistant Pathogen

Maria Michelina Raso et al.

Summary: Shigellosis is a global health concern, causing over 200,000 deaths worldwide, particularly in low- and middle-income countries and young children. The emergence of antimicrobial-resistant strains has made Shigella even more worrisome, leading to the prioritization of this pathogen by the WHO for new intervention development. Despite the lack of broadly available vaccines, ongoing research is providing important insights into Shigella epidemiology, pathogenesis, and potential antigens for vaccine development. Additionally, different technologies are being explored for the creation of a vaccine with broad protection against Shigella.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Review Immunology

Functional assays to evaluate antibody-mediated responses against Shigella: a review

Elena Boero et al.

Summary: Shigella is a major global pathogen causing shigellosis, primarily affecting low- and middle-income countries. The role of antibodies in Shigella pathogenesis remains to be elucidated, especially since Shigella is mostly an intracellular pathogen. In vitro assays are important tools to evaluate the functionality of anti-Shigella antibodies, and animal models have been established to partially recapitulate human pathogenesis.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Shigella Outer Membrane Vesicles as Promising Targets for Vaccination

Muhammad Qasim et al.

Summary: Shigellosis is a gastrointestinal infection caused by Shigella spp. The currently available vaccines have been ineffective in preventing this infection. Outer membrane vesicles (OMVs) are promising novel targets for vaccination due to their immunomodulatory, antigenic and adjuvant properties.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Agriculture, Dairy & Animal Science

Shigella flexneri vaccine development: Oral administration of peptides derived from the 49.8 kDa pili protein subunit activates the intestinal immune response in mice

Khoirul Anam et al.

Summary: This study found that the selected peptides can activate cellular and humoral immune responses in the intestines of mice, which can help in the development of new Shigella vaccines. Further research is needed to optimize antigen delivery and evaluate whether these peptides can prevent bacterial infections.

VETERINARY WORLD (2022)

添加到收藏夹

Article Immunology

Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group

Patricia B. Pavlinac et al.

Summary: This article discusses the trial design for Shigella vaccines to meet the regulatory requirements and prevent moderate or severe Shigella infections caused by the strains included in the vaccine. The primary endpoint of the vaccine trials is to evaluate the efficacy of the vaccine against the first episode of acute moderate or severe diarrhea.

VACCINES (2022)

添加到收藏夹

Review Microbiology

Outer membrane vesicles: A bacterial-derived vaccination system

Linda A. Lieberman

Summary: Outer membrane vesicles (OMVs) derived from Gram-negative bacteria have various important roles and applications, including bacterial pathogenesis, cell-to-cell communication, gene transfer, quorum sensing, and maintenance of bacterial fitness. OMVs can be modified to express antigens, making them suitable for immunization and potential drug delivery. This review highlights the manipulation of OMVs, their use as vaccines, and novel engineering approaches to expand their applications.

FRONTIERS IN MICROBIOLOGY (2022)

添加到收藏夹

Article Immunology

Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens

Gianmarco Gasperini et al.

Summary: Generalized modules for membrane antigens (GMMA) are exosomes released from engineered Gram-negative bacteria and can be used as a vaccine platform to deliver O-antigen, providing protective immunity against various pathogens. By engineering, different GMMA can be obtained, including serotypes that do not exist naturally.

NPJ VACCINES (2022)

添加到收藏夹

Review Immunology

The Shigella Vaccines Pipeline

Calman Alexander MacLennan et al.

Summary: This report outlines the requirements for a Shigella vaccine and describes the current pipeline of research projects. Despite the existence of numerous vaccine candidates, no vaccine has been licensed yet for various reasons. Once the results of clinical trials among young children in low- and middle-income countries are available, the timeline for the licensure of the first Shigella vaccine will become clearer.

VACCINES (2022)

添加到收藏夹

Review Health Care Sciences & Services

Intradermal Vaccination: A Potential Tool in the Battle Against the COVID-19 Pandemic?

Alberto Migliore et al.

Summary: The narrative review suggests that fractional intradermal vaccination can be an effective and efficient strategy for certain vaccines such as influenza, rabies, and hepatitis B. More research is needed for vaccines against other pathogens, but initial findings are promising. During a shortage of COVID-19 vaccines, exploring fractional dosing schemes could help save doses and achieve herd immunity quickly.

RISK MANAGEMENT AND HEALTHCARE POLICY (2021)

添加到收藏夹

Article Immunology

Functional Antibodies and Innate Immune Responses to WRSS1, a Live Oral Shigella sonnei Vaccine Candidate, in Bangladeshi Adults and Children

Protim Sarker et al.

Summary: This study demonstrated that the WRSS1 vaccine is safe and induces antigen-specific antibodies in Bangladeshi adults and children. Children showed increased functional antibodies and Th1/Th17 cytokine responses after vaccination, suggesting important immunogenicity and protective potential of WRSS1.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Cell Biology

Shigella impairs human T lymphocyte responsiveness by hijacking actin cytoskeleton dynamics and T cell receptor vesicular trafficking

Fatoumata Samassa et al.

CELLULAR MICROBIOLOGY (2020)

添加到收藏夹

Article Immunology

Intranasal Immunization of Mice with Multiepitope Chimeric Vaccine Candidate Based on Conserved Autotransporters SigA, Pic and Sap, Confers Protection against Shigella flexneri

Yrvin Leon et al.

VACCINES (2020)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses

Katja Brunner et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)

添加到收藏夹

Article Immunology

Dissolving Microneedles for Intradermal Vaccination against Shigellosis

Yadira Pastor et al.

VACCINES (2019)

添加到收藏夹

Article Immunology

Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays

Robert W. Kaminski et al.

CLINICAL INFECTIOUS DISEASES (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Understanding the basis of transcutaneous vaccine delivery

Carlos Gamazo et al.

THERAPEUTIC DELIVERY (2019)

添加到收藏夹

Article Infectious Diseases

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Evelina Tacconelli et al.

LANCET INFECTIOUS DISEASES (2018)

添加到收藏夹

Article Infectious Diseases

Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016

Ibrahim A. Khalil et al.

LANCET INFECTIOUS DISEASES (2018)

添加到收藏夹

Article Immunology

Towards a subunit vaccine from a Shigella flexneri Delta tolR mutant

Yadira Pastor et al.

VACCINE (2018)

添加到收藏夹

Article Immunology

Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study

Avital A. Shimanovich et al.

CLINICAL AND VACCINE IMMUNOLOGY (2017)

添加到收藏夹

Article Microbiology

Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine

Yadira Pastor et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe

Odile Launay et al.

EBIOMEDICINE (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout

Francesca Necchi et al.

PLOS ONE (2017)

添加到收藏夹

Article Immunology

Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain

Soma Mitra et al.

VACCINE (2016)

添加到收藏夹

Article Immunology

Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development

Sofie Livio et al.

CLINICAL INFECTIOUS DISEASES (2014)

添加到收藏夹

Article Immunology

Intradermal Delivery of Shigella IpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes

Shannon J. Heine et al.

JOURNAL OF IMMUNOLOGY (2014)

添加到收藏夹

Review Gastroenterology & Hepatology

Progress and pitfalls in Shigella vaccine research

Eileen M. Barry et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)

添加到收藏夹

Article Immunology

Nanoparticle-based vaccine for mucosal Shigella flexneri in mice

A. I. Camacho et al.

VACCINE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

High Yield Production Process for Shigella Outer Membrane Particles

Francesco Berlanda Scorza et al.

PLOS ONE (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.